Direct contact between drug-consumers and the pharmaceutical industry is forecast by Edward Roberts, head of the pharmaceutical division of German drugmaker E Merck of Darmstadt and chairman of Pharmaceutical Partners for Better Healthcare. He cited a recent conference on cancer in Philadelphia, USA, where results of a Merck research-based drug study were presented on the Internet two days later.
Mr Roberts said this meant that patients visiting this Internet site already knew more about the product two days later than did 99.9% of Merck's own work colleagues. He added that the technology would lead to an explosion in generally available drug data, with the drug industry in future facing better-informed patients.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze